Sign in

NCT06029114Enrolling by invitation

MR Elastography of Cognitive Impairment

Magnetic Resonance Elastography of Cognitive Impairment

Source: ClinicalTrials.gov · Last updated 13 Jan 2026

Brief summary (registry, in English)

The purpose of this research is to further investigate the potential of brain stiffness as a novel biomarker for Alzheimer's disease.

Status (registry)
Enrolling by invitation
Study type
Observational
Enrollment
450 (estimated)
First submitted
1 Sept 2023
Start date
11 Oct 2023
Primary completion date
Nov 2027
Lead sponsor
Mayo Clinic
NCT number
NCT06029114

What you commit to

  • Study type: Observational
  • Planned participants: 450
  • From 11 Oct 2023 to the primary completion date, Nov 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Pregnant women. Women of child bearing potential will be given a urine pregnancy test prior the MRI scan. Results will be shared with the participant. If the pregnancy test is positive, the participant will not be included within the study

Other illness

  • Alzheimer's disease or mild cognitive impairment due to a known genetic mutation
  • History of primary or metastatic intracranial neoplasm, significant head trauma, intra-cerebral hemorrhage, hemispheric stroke
  • Contradictions to MRI imaging including but not limited to cardiac pacemakers, intraocular or intracranial metal, or other MRI incompatible devices.

Other

  • Major depression

Who the study is looking for

  • In good general health
  • No Active neurological or psychiatric conditions, if a prior neurological or psychiatric condition was present they must have returned to normal
  • No cognitive complaints
  • Normal neurological examination
  • No psychoactive medications
  • They may have a chronic medical condition that does not affect cognition
  • Low Aβ load Pittsburgh compound-B (PiB) ratio \<1.5
  • In good general health
  • Memory complaint documented by the patient and collateral source
  • Normal general cognitive function as determined by measure of general intellectual function and screening including the Short Test of Mental Status
  • Normal activities of daily living as documented by history and Record of Independent Living
  • Not demented by DSM-III-R criteria
  • Do have an objective memory impairment determined by the clinical judgement of the neuropsychologists and neurologists
  • High Aβ load Pittsburgh compound-B (PiB) ratio ≥1.5
  • In good general health
  • Dementia not a result of other medical or psychiatric conditions
  • Diagnosis of dementia made according to DSM-III-R criteria
  • Do have objective memory impairment determined by the clinical judgement of the neuropsychologists and neurologists
  • High Aβ load Pittsburgh compound-B (PiB) ratio ≥1.5

Age in the registry: 18 years to 100 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Mayo Clinic Minnesota
Coordinator of this site? Confirm its status
RochesterUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.